MedPath

Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Cardiac Surgery
Registration Number
NCT06791551
Lead Sponsor
China National Center for Cardiovascular Diseases
Brief Summary

Perioperative neurological complications in cardiovascular surgical procedures are associated with a significant risk of mortality and disability. The goal of this clinical trial is to learn if ischemic preconditioning and transcranial electrical stimulation to reduce perioperative neurological complications. It will also learn about the safety of remote ischemic preconditioning and transcranial electrical stimulation before cardiac surgery. The main questions it aims to answer are "Do remote ischemic preconditioning and transcranial electrical stimulation make good effect on perioperative neurological complications?" "Are remote ischemic preconditioning and transcranial electrical stimulation safe?" Researchers will compare remote ischemic preconditioning and transcranial electrical stimulation to traditional treatment to see if remote ischemic preconditioning and transcranial electrical stimulation work to reduce perioperative neurological complications.

Participants will:Undergo remote ischemic preconditioning and transcranial electrical stimulation or sham treatment twice every day for 3 days before surgery.

Undertake psychological assessment and clinical symptom follow-up after cardiac surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Age range: 18-80 years old;
  2. Surgical patients with heart disease;
  3. Elective surgery;
  4. Patients identified as high-risk for postoperative neurological complications; Previous stroke history; Moderate to severe stenosis of the head and neck arteries was evaluated;
  5. Be able to understand and comply with the requirements of clinical trial protocols, and voluntarily sign informed consent forms.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The incidence of neurological complications 7 (± 3) days after cardiac surgeryFrom enrollment to the post-surgery within 7 (±3) days

Lethal or non lethal stroke, coma, or motor impairment; Cognitive impairment or delirium

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Neurology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing,

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath